Related Experiment Video
Updated: Jun 4, 2026
08:15
Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
Mitochondrial polymorphisms associated with differential longevity do not impact lifetime-reproductive success
Loredana Castrì1, Lorena Madrigal, Mauricio Melendez-Obando
1Dipartimento di Biologia evoluzionistica sperimentale, Area di Antropologia, Università di Bologna, Bologna, Italy.
Summary
Mitochondrial DNA markers linked to longevity do not influence reproductive success. This suggests these longevity-associated polymorphisms do not impact an individual's Darwinian fitness.
Area of Science:
- Evolutionary biology
- Genetics
- Demography
Background:
- Mitochondrial DNA (mtDNA) markers have been associated with variations in human longevity.
- Understanding the link between longevity and reproductive success is crucial for evolutionary studies.
Observation:
- This study investigated whether specific mtDNA markers (5178A in haplogroup D and 150T polymorphism) influence lifetime reproductive success (LRS).
- Maternal genealogies were reconstructed for subjects in Atenas, Costa Rica, to assess LRS and longevity of ancestors.
- The LRS of women with longevity-associated polymorphisms (LAPs) was compared to controls born between 1750 and 1939.
Findings:
- Women carrying LAPs did not exhibit differential LRS compared to controls.
- Significant differences in longevity between LAP carriers and controls were observed, but this did not translate to reproductive success.
Implications:
- Longevity-associated polymorphisms do not appear to confer a selective advantage or disadvantage in terms of reproductive output.
- These findings suggest that evolutionary fitness, as measured by LRS, is not directly modulated by these specific longevity-influencing mtDNA markers.
Related Concept Videos
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Non-nuclear Inheritance
Most DNA resides in the nucleus of a cell. However, some organelles in the cell cytoplasm—such as chloroplasts and mitochondria—also have their own DNA. These organelles replicate their DNA independently of the nuclear DNA of the cell in which they reside. Non-nuclear inheritance describes the inheritance of genes from structures other than the nucleus.